Your session is about to expire
← Back to Search
Neuromodulation for Gastroparesis (TNM-DGp Trial)
TNM-DGp Trial Summary
This trial is testing a new noninvasive treatment for gastroparesis that uses neuromodulation to improve symptoms. The hypothesis is that this new treatment will be better than a sham treatment at improving symptoms.
TNM-DGp Trial Eligibility Criteria
Inclusion Criteria
You may be eligible if you check “Yes” for the criteria belowTNM-DGp Trial Timeline
Treatment Details
Study Objectives
Outcome measures can provide a clearer picture of what you can expect from a treatment.TNM-DGp Trial Design
Find a Location
Who is running the clinical trial?
Media Library
- I have had surgery on my stomach before.I am receiving nutrition through a feeding tube or IV.I have slow stomach emptying after surgery.I do not have any known diseases affecting the moist tissues of my body.I have been on the same medication doses for 30 days, except for certain drugs, and agree not to change them during the study.I am younger than 85 years old.I am currently taking medication that stimulates my nervous system.I do not have severe heart disease or irregular heartbeats.You are an outpatient with persistent symptoms and a moderate to severe ANMS GCSI-DD score.I have a history of seizures.You have a serious mental illness that needs separate treatment.I have an active inflammatory bowel condition.I haven't changed my dosage of medications like antidepressants or gabapentin in the last 3 months.I have a diagnosed digestive disorder and less than one bowel movement every 2 weeks.People with ongoing digestive symptoms and a high score on a specific symptom scale will not be included.I have been on the same medication doses for 30 days and won't change them during the study.You have metal implants that are not safe for MRI, or devices like gastric electrical stimulators, deep brain stimulators, sacral nerve stimulators, or pacemakers.I am younger than 85 years old.I have a blockage in my digestive tract.I do not have any known diseases affecting the moist linings of my body.You use opioids more than 3 times a week and marijuana more than 5 times a week.
- Group 1: 1Hz Arm
- Group 2: 10Hz Arm
- Group 3: Sham Arm
- Screening: It may take up to 3 Weeks to process to see if you qualify in this trial.
- Treatment: The duration you will receive the treatment varies.
- Follow Ups: You may be asked to continue sharing information regarding the trial for 6 Months after you stop receiving the treatment.
Frequently Asked Questions
Am I eligible to take part in this research initiative?
"This study has 48 places for outpatients, aged 18-85, with gastroparesis and refractory symptoms. Other criteria include: no known mucosal diseases; fluency in English (as self-reported); and having been on a consistent dose of any medications (excluding psychotropic drugs or opioids) within the previous 30 days - without changes during the trial duration."
To what extent is participation in this research opportunity being limited?
"Affirmative. According to clinicaltrials.gov, the research is open for enrollment and has been since its initial posting on June 27th 2022; it was last edited two days later on June 29th. Currently, 48 patients are required across a single site."
Is this research presently open to enrollment?
"Indeed, the current information hosted on clinicaltrials.gov reveals that recruitment for this medical trial is still ongoing; the study was initially posted on June 27th 2022 and last updated two days later. This research requires 48 individuals from 1 location to take part in it."
Does this experiment have any age restrictions for participating participants?
"This medical experiment has strict age criteria with a lower limit of 18 years old and an upper bound of 85."
Who else is applying?
What state do they live in?
How old are they?
What site did they apply to?
What portion of applicants met pre-screening criteria?
Why did patients apply to this trial?
Share this study with friends
Copy Link
Messenger